Omphalos Lifesciences

Omphalos Signs MOU with FuriosaAI, KRIBB KPEC, Yonsei University, and Insilicox

We are excited to share that Omphalos Lifesciences Inc has joined a new industryโ€“academiaโ€“research consortium to accelerate ๐—”๐—œ-๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ฑ๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐˜‚๐˜€๐—ถ๐—ป๐—ด ๐—ป๐—ฒ๐˜…๐˜-๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฐ๐—ผ๐—บ๐—ฝ๐˜‚๐˜๐—ถ๐—ป๐—ด ๐—ถ๐—ป๐—ณ๐—ฟ๐—ฎ๐˜€๐˜๐—ฟ๐˜‚๐—ฐ๐˜๐˜‚๐—ฟ๐—ฒ. On March 13, Omphalos Korea signed an MOU with FuriosaAI, Korea Research Institute of Bioscience and Biotechnology (KRIBB) Korea Preclinical Evaluation Center (KPEC), Yonsei University College Read more…